TrialCellular and molecular gastroenterology and hepatology2020

Netazepide Inhibits Expression of Pappalysin 2 in Type 1 Gastric Neuroendocrine Tumors.

Katie A Lloyd et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.